Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Feagan

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
JAMA|February 22, 2000
A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing LevofloxacinT J Marrie, C Y Lau, S L Wheeler, et al.
Alimentary Pharmacology & Therapeutics|January 13, 2011
Randomised clinical trial: improvement in health outcomes with certolizumab pegol in patients with active Crohn's disease with prior loss of response to infliximabB G Feagan, W J Sandborn, D C Wolf, et al.
Transfusion Medicine (Oxford, England)|April 12, 2001
Transfusion practice in elective orthopaedic surgeryB G Feagan, C J Wong, C Y Lau, et al.
Advances in Therapy|October 26, 2021
Economic Evaluation of Budesonide Orodispersible Tablets for the Treatment of Eosinophilic Esophagitis: A Cost-Utility AnalysisC Beauchemin, A Castonguay, E S Chan, et al.
Annals of Internal Medicine|December 5, 2000
Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trialB G Feagan, C J Wong, A Kirkley, et al.
Inflammatory Bowel Diseases|August 29, 2000
Quality of life rapidly improves with budesonide therapy for active Crohn's disease. Canadian Inflammatory Bowel Disease Study GroupE J Irvine, G R Greenberg, B G Feagan, et al.
Gastroenterology|January 1, 1996
Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study GroupG R Greenberg, B G Feagan, F Martin, et al.
The New England Journal of Medicine|September 29, 1994
Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study GroupG R Greenberg, B G Feagan, F Martin, et al.
The New England Journal of Medicine|June 30, 1994
Low-dose cyclosporine for the treatment of Crohn's disease. The Canadian Crohn's Relapse Prevention Trial InvestigatorsB G Feagan, J W McDonald, J Rochon, et al.
Gastroenterology|June 26, 1999
Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohortM D Silverstein, E V Loftus, W J Sandborn, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
JAMA|February 22, 2000
A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing LevofloxacinT J Marrie, C Y Lau, S L Wheeler, et al.
Alimentary Pharmacology & Therapeutics|January 13, 2011
Randomised clinical trial: improvement in health outcomes with certolizumab pegol in patients with active Crohn's disease with prior loss of response to infliximabB G Feagan, W J Sandborn, D C Wolf, et al.
Transfusion Medicine (Oxford, England)|April 12, 2001
Transfusion practice in elective orthopaedic surgeryB G Feagan, C J Wong, C Y Lau, et al.
Advances in Therapy|October 26, 2021
Economic Evaluation of Budesonide Orodispersible Tablets for the Treatment of Eosinophilic Esophagitis: A Cost-Utility AnalysisC Beauchemin, A Castonguay, E S Chan, et al.
Annals of Internal Medicine|December 5, 2000
Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trialB G Feagan, C J Wong, A Kirkley, et al.
Inflammatory Bowel Diseases|August 29, 2000
Quality of life rapidly improves with budesonide therapy for active Crohn's disease. Canadian Inflammatory Bowel Disease Study GroupE J Irvine, G R Greenberg, B G Feagan, et al.
Gastroenterology|January 1, 1996
Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study GroupG R Greenberg, B G Feagan, F Martin, et al.
The New England Journal of Medicine|September 29, 1994
Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study GroupG R Greenberg, B G Feagan, F Martin, et al.
The New England Journal of Medicine|June 30, 1994
Low-dose cyclosporine for the treatment of Crohn's disease. The Canadian Crohn's Relapse Prevention Trial InvestigatorsB G Feagan, J W McDonald, J Rochon, et al.
Gastroenterology|June 26, 1999
Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohortM D Silverstein, E V Loftus, W J Sandborn, et al.
Pageof 8